-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROCRINE BIOSCIENCES - Q3 2026 REVENUE GREW 41% YEAR-OVER-YEAR TO $1.10 BLN - SEC FILING

Reuters·11/02/2026 21:34:14

Please log in to view news